Technical Analysis for BCTX - BriaCell Therapeutics Corp.

Grade Last Price % Change Price Change
F 2.90 -1.69% -0.05
BCTX closed down 1.69 percent on Monday, March 18, 2024, on approximately normal volume. The bears made the stock sink to a new 52-week low. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Narrow Range Bar Range Contraction -1.69%
Inside Day Range Contraction -1.69%
Oversold Stochastic Weakness -1.69%
New Downtrend Bearish -2.68%
Lizard Bullish Bullish Day Trade Setup -2.68%

   Recent Intraday Alerts

Alert Time
Lower Bollinger Band Support about 11 hours ago
2x Volume Pace about 12 hours ago
3x Volume Pace about 12 hours ago
Down 10% about 12 hours ago
1.5x Volume Pace about 12 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Immune System Immunotherapy Oncology Breast Cancer Treatment Of Breast Cancer Immune Checkpoint National Cancer Institute Advanced Breast Cancer

Is BCTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.75
52 Week Low 2.6206
Average Volume 90,055
200-Day Moving Average 5.22
50-Day Moving Average 3.76
20-Day Moving Average 3.23
10-Day Moving Average 3.01
Average True Range 0.26
RSI (14) 31.97
ADX 28.46
+DI 9.63
-DI 31.96
Chandelier Exit (Long, 3 ATRs) 2.96
Chandelier Exit (Short, 3 ATRs) 3.39
Upper Bollinger Bands 3.72
Lower Bollinger Band 2.74
Percent B (%b) 0.17
BandWidth 30.49
MACD Line -0.24
MACD Signal Line -0.24
MACD Histogram -0.0003
Fundamentals Value
Market Cap 46.35 Million
Num Shares 16 Million
EPS -1.73
Price-to-Earnings (P/E) Ratio -1.68
Price-to-Sales 0.00
Price-to-Book 23.02
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.44
Resistance 3 (R3) 3.41 3.19 3.35
Resistance 2 (R2) 3.19 3.06 3.21 3.32
Resistance 1 (R1) 3.05 2.97 2.94 3.08 3.29
Pivot Point 2.83 2.83 2.78 2.85 2.83
Support 1 (S1) 2.69 2.70 2.58 2.72 2.51
Support 2 (S2) 2.47 2.61 2.49 2.48
Support 3 (S3) 2.33 2.47 2.45
Support 4 (S4) 2.36